New study aims to unravel the mysteries of PCOS in french women
NCT ID NCT07339930
First seen Jan 16, 2026 · Last updated Jun 18, 2026 · Updated 23 times
Summary
This study is observing 100 women with polycystic ovary syndrome (PCOS) in Alsace, France to learn more about the condition. Researchers will measure things like obesity rates and insulin resistance to better understand the different types of PCOS. The goal is to improve diagnosis and awareness, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME (PCOS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ervice d'Endocrinologie, Diabétologie et Nutrition - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.